Related Experiment Video

Updated: Jun 12, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Community-wide survey of physicians' knowledge of cholesterol management

Fei Guan1, Jiang Xie, Gui-Lian Wang

  • 1Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.

Chinese Medical Journal
|May 26, 2010
PubMed

Insights

Community physicians demonstrate poor knowledge of cholesterol guidelines and lipid management, impacting coronary heart disease prevention. Targeted education is crucial to improve adherence to lipid-lowering treatment protocols.

Area of Science:

  • Cardiology
  • Public Health
  • Medical Education

Background:

  • Elevated serum lipids are a major risk factor for coronary heart disease (CHD).
  • Physician awareness of practice guidelines is vital for effective chronic disease management.
  • Community medical centers play a key role in primary disease prevention.

Purpose of the Study:

  • To assess community physicians' awareness of current cholesterol guidelines.
  • To evaluate the utilization of these guidelines in clinical practice.

Main Methods:

  • A confidential, semi-structured questionnaire was administered to 601 randomly selected community physicians across four regions.
  • A total of 486 valid questionnaires were analyzed.

Main Results:

  • Physicians exhibited poor fundamental knowledge of lipids and low awareness of cholesterol guidelines.
  • Only 24% and 14% correctly identified optimal low-density lipoprotein cholesterol (LDL-C) levels for CHD and diabetes patients, respectively.
  • Over half of physicians mistakenly believed elevated transaminases were a lethal statin side effect, with 51.9% discontinuing statin treatment due to transaminase elevation.

Conclusions:

  • Significant educational interventions are required to enhance cholesterol knowledge among Chinese community physicians.
  • Dissemination of standard lipid management protocols is necessary to improve patient outcomes.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...